Associations between interleukin-1 gene polymorphisms and sepsis risk: a meta-analysis

  • An-qiang Zhang1,

    Affiliated with

    • Wei Pan1,

      Affiliated with

      • Jun-wei Gao1,

        Affiliated with

        • Cai-li Yue1,

          Affiliated with

          • Ling Zeng1,

            Affiliated with

            • Wei Gu1 and

              Affiliated with

              • Jian-xin Jiang1Email author

                Affiliated with

                BMC Medical Genetics201415:8

                DOI: 10.1186/1471-2350-15-8

                Received: 10 August 2013

                Accepted: 12 January 2014

                Published: 16 January 2014

                Abstract

                Background

                Previous epidemiological studies have presented conflicting evidence regarding associations between interleukin-1 (IL-1) polymorphisms and sepsis susceptibility. We have performed a meta-analysis to evaluate possible associations between IL-1 polymorphisms and sepsis risk.

                Methods

                Eligible literature was retrieved from PubMed, Embase and Web of Knowledge databases until Jun 15, 2013. The pooled odds ratio (OR) and 95% confidence interval (CI) were calculated using random-effects model in the overall and subgroup analysis based on ethnicity, sepsis severity and quality score.

                Results

                Eighteen studies addressing five IL-1 polymorphisms were included in this meta-analysis. For IL-1A-889 (rs1800587) polymorphism, significant association was observed in overall comparison for allelic effect (OR = 1.47, 95% CI = 1.01-2.13, P = 0.04). There were no significant associations between either IL-1B-511 (rs16944) or IL-1B-31 (rs1143627) and sepsis susceptibility in overall or subgroup analyses. For IL-1B + 3594 (rs143634) polymorphism, genotype TT decreased sepsis risk in overall analysis (OR = 0.59, 95% CI = 0.36-0.97, P = 0.04), as well as in Caucasian (OR = 0.57, 95% CI = 0.34-0.95, P = 0.03) and sepsis (OR = 0.55, 95% CI = 0.31-0.97, P = 0.04) subgroup analysis. For IL-1RN VNTR polymorphism, significant association was observed in overall comparison for allelic effect (OR = 1.40, 95% CI = 1.01-1.95, P = 0.04). Furthermore, the effect sizes of IL-1RN VNTR on sepsis risk increased with disease severity (septic shock OR > severe sepsis OR > sepsis OR).

                Conclusions

                Our meta-analysis indicated that IL-1A-889, IL-1B + 3954 and IL-1RN VNTR might be associated with sepsis susceptibility. However, further studies with larger sample sizes and from homogenous populations would be necessary to validate these findings.

                Keywords

                Sepsis IL-1 Polymorphism Meta-analysis

                Background

                Sepsis is a complex clinical syndrome that results from a systemic inflammatory response to bacteria and/or bacterial products [1]. Though there have been many advances in the development of antibiotics and supportive care, sepsis remains a serious and deadly problem with high mortality rates worldwide [2]. Therefore, predictive markers to identify high-risk patients are urgently needed for early detection and preventive care of sepsis. Cytokines play vital roles in the regulation of host immune response, and altered expression of cytokines is proven to be involved the development of sepsis [3]. Previous research suggests that the variations in the genes encoding cytokines are also involved in the inflammatory responses and are responsible for inter-individual differences in susceptibility to sepsis and in its severity [4]. Delineating the variations in cytokine genes, and associated differences in response to sepsis might contribute to the development of new genetically tailored diagnostic and therapeutic interventions that may improve outcome in sepsis patients.

                Interleukin-1 (IL-1) family is a critical mediator of immune response to sepsis with two agonists (IL-1α and IL-1β) and one antagonist (IL-1 receptor antagonist: IL-1ra) [57]. Excessive IL-1 production is directly linked to the development of shock, multi-organ system failure, and death in patients and animals with sepsis, systemic inflammatory response syndrome, and septic shock [7]. Clinical trials with recombinant IL-1ra in the treatment of sepsis showed the highest mortality rate in those patients treated with the largest dose of IL-1ra, suggesting that overproduction of either pro-inflammatory mediators (IL-1α and IL-1β) or anti-inflammatory cytokines (IL-1ra) might lead to organ dysfunction and even death [8].

                IL-1A, IL-1B and IL-1RN genes (encoding IL-1α, IL-1β, and IL-1ra, respectively) are located next to each other within the cluster of human major histocompatibility complex in the q13-21 area of human chromosome 2 [9]. Five SNPs in IL-1 genes have been most frequently studied in relation to sepsis risk: one SNP at promoter position −889 in the IL-1A gene, two SNPs at promoter position −511 and −31 and one SNP in exon 5 at position +3954 of the IL-1B gene and a variable number of tandem repeats (VNTR) of 86-bp sequence in intron 2 of IL-1RN gene, 5 alleles of which have been reported (1 to 5) corresponding to 4, 2, 5, 3 and 6 copies of 86-bp sequence, respectively. Thus, the IL-1RN alleles were further divided into two categories: long genotype (L: including alleles 1, 3, 4, and 5) and short genotype (2: allele 2 only). The genotypes were classified as L/L, L/2, and 2/2 [10].

                Recently, a number of studies regarding the associations between IL-1 polymorphisms and sepsis risk have been published [1127]. However, the results reported from these studies are inconsistent and inconclusive. We performed a meta-analysis to further investigate the associations between IL-1 polymorphisms and sepsis risk, which may help us to better clarify the effect of these polymorphisms on sepsis susceptibility.

                Methods

                Identification and eligibility of relevant study

                Relevant articles were identified through a literature search using the keywords “IL-1 or interleukin-1 or IL1” and “sepsis or severe sepsis or septic shock” and “polymorphism or genetic variant or mutation” in Pubmed, Embase, and Web of Knowledge databases until Jun 15, 2013. All searched articles were retrieved and their references were checked for other relevant publications.

                The inclusion criteria were: (a) studies evaluating the association between IL-1 polymorphisms and sepsis risk, (b) case–control study or cohort design, (c) sufficient data (genotype distributions of cases and controls), and (d) studies written in English. We excluded reviews, comments and articles from which the necessary data could not be extracted nor obtained after contacting the authors. In cases of overlapping studies, only the study with the largest sample size was included.

                To minimize the bias and improve the reliability, two researchers reviewed these articles with the inclusion and exclusion criteria independently and reached a consensus.

                Data extraction

                Data extraction was independently performed by two investigators and discrepancies were settled by reaching a consensus. Information such as the first author’s name, publication year, country and ethnicity of participants, sepsis severity, genotyping method, genotype number or allele frequencies for cases and controls was collected from each study using a standardized data collection protocol. For studies including subjects of different populations, data were extracted separately.

                Qualitative assessment

                Quality assessment was performed with the Newcastle-Ottawa quality assessment scale (NOS) [28]. A ‘star system’ has been used to judge data quality based on three broad perspectives: the selection, comparability and outcome of interest. Stars are added up to compare the study quality in a quantitative fashion. The scores ranged from 0 to 9 stars. Studies with scores of 7 stars or greater were considered to be of high quality. Based on these criteria, the content validity was evaluated by J-WG and C-LY, and any disagreement was resolved via discussions between and or with the other authors for adjudication.

                Statistical analysis

                The associations between IL-1 polymorphisms and sepsis risk were estimated by calculating pooled ORs and 95%CI under the dominant (BB + AB vs. AA), recessive (BB vs. AB + AA), and allelic (B vs. A) genetic models respectively (B represented minor allele, A represented major allele). A random-effects model, using Mantel-Haenszel method, was used to calculate pooled ORs. The significance of pooled ORs was determined with Z tests (P < 0.05 was considered statistically significant). Departure from Hardy-Weinberg equilibrium (HWE) in controls was tested via a Chi-square test at a significance level of P < 0.05. Heterogeneity between studies was assessed using the Cochrane Q test and the I2 statistic [29]. Multivariate meta-regression was performed to explore potential sources of heterogeneity among the following covariates: ethnicity (divided into Asian, Caucasian and others), sepsis severity (divided into sepsis, severe sepsis and septic shock), sources of controls (divided into community- or hospital-based) and sample size using REML method of random-effects when the number of studies was more than or equal to 10 [30]. Subgroup analyses were carried out based on ethnicity, severity of sepsis, and quality score. To assess the stability of the pooled results, sensitivity analysis was performed by sequentially excluding individual studies one by one. The publication bias was examined by funnel plot [31] and Egger’s test [32]. To adjust the values for multiple comparisons in subgroup analyses, we used the Benjamini-Hochberg (BH) step-up correction method, which control the false discovery rate (FDR) [33]. All statistical tests were performed using Review Manager 5.2 (The Cochrane Collaboration, Oxford, UK) and STATA11.0 software (StataCorp LP, College Station, Texas, USA).

                Result

                Characteristics of eligible studies

                A total of 429 articles were identified update to Jun 15, 2013 (107 from PubMed, 144 from Embase, and 178 from Web of Knowledge). After scanning the abstracts and checking the full-text articles, seventeen articles met the inclusion criteria. Furthermore, two populations containing Caucasian and Black subjects were included in one article by Johnson et al. [13] which was therefore considered as two independent studies (referred to as Johnson-1 and Johnson-2) in the following data analysis. Thus, 18 studies addressing five polymorphisms in IL-1 gene were included in our meta-analysis (Flow diagram shown in Figure 1).
                http://static-content.springer.com/image/art%3A10.1186%2F1471-2350-15-8/MediaObjects/12881_2013_1167_Fig1_HTML.jpg
                Figure 1

                Flow of study identification, inclusion, and exclusion. *represents that certain studies will appear in more than one group when they are divided by polymorphism.

                The characteristics of included studies are listed in Table 1. Of these 18 studies, eight were conducted in Caucasian, six in Asian, two in Hispanic, one in African-American, and one in Jewish/Arabic populations. Except for one study for IL-1B + 3594 and another for IL-1RN VNTR, the genotype frequency distributions of others were in agreement with HWE (Table 1). Quality scores for individual studies ranged from 6 to 9, with 78% (14 of 18) of the studies being classified as high quality (score ≥ 7) (Additional file 1: Table S1). The classical polymerase chain reaction (PCR) and PCR-restriction fragment length polymorphism (PCR-RFLP) were the most commonly used genotyping method in these studies.
                Table 1

                Characteristics of studies included in the meta-analysis

                Author/Year

                Country

                Ethnicity

                Sepsis severity

                Sources of control

                Genotyping method

                Quality score

                Case/control

                Case

                Control

                PHWE

                AA

                AB

                BB

                AA

                AB

                BB

                 

                IL1α-889C/T

                              

                Davis 2010

                America

                Hispanic

                Sepsis

                Community

                TaqMan

                7

                28/52

                9

                16

                3

                24

                24

                4

                0.55

                Gu 2010

                China

                Asian

                Sepsis

                Hospital (trauma)

                Probes

                8

                165/141

                114

                42

                9

                107

                31

                3

                0.67

                IL-1B-511G/A

                              

                Johnson-1 2012

                America

                Caucasian

                Sepsis

                Hospital (noninfected)

                Mass-array

                9

                245/263

                103

                114

                28

                101

                120

                42

                0.53

                Johnson-2 2012

                America

                African-American

                Sepsis

                Hospital (noninfected)

                Mass-array

                9

                93/88

                28

                36

                29

                26

                43

                19

                0.88

                Wan 2012

                China

                Asian

                Sepsis

                Hospital (transplanted)

                PCR-RFLP

                7

                21/60

                11

                6

                4

                12

                30

                18

                0.94

                Shimada 2011

                Japan

                Asian

                Sepsis

                Hospital (critical ill)

                Probes

                7

                123/101

                33

                60

                30

                35

                46

                20

                0.49

                Davis 2010

                America

                Hispanic

                Sepsis

                Community

                TaqMan

                7

                28/53

                17

                6

                5

                19

                29

                5

                0.20

                Gu 2010

                China

                Asian

                Sepsis

                Hospital (trauma)

                Probes

                8

                167/140

                57

                83

                27

                34

                61

                45

                0.15

                Watanabe 2005

                Japan

                Asian

                Sepsis

                Hospital (SIRS)

                Probes

                6

                68/45

                19

                 

                49a

                20

                 

                25a

                0.86

                IL-1B-31C/T

                              

                Shimada 2011

                Japan

                Asian

                Sepsis

                Hospital (critical ill)

                Probes

                8

                122/101

                36

                58

                28

                34

                47

                20

                0.61

                Emonts 2010

                Netherlands

                Caucasian

                Sepsis

                Community

                SNaPshot

                7

                84/456

                10

                37

                37

                57

                214

                185

                0.69

                Gu 2010

                China

                Asian

                Sepsis

                Hospital (trauma)

                Probes

                8

                163/144

                29

                106

                28

                66

                60

                18

                0.45

                Barber 2004

                America

                Caucasian

                SS

                Hospital (burn)

                Pyro

                8

                36/123

                11

                13

                12

                21

                54

                48

                0.39

                IL-1B + 3594C/T

                              

                Johnson-1 2012

                America

                Caucasian

                Sepsis

                Hospital (noninfected)

                Mass-array

                9

                245/263

                148

                89

                8

                158

                88

                17

                0.32

                Johnson-2 2012

                America

                African-American

                Sepsis

                Hospital (noninfected)

                Mass-array

                9

                93/88

                61

                29

                3

                65

                20

                3

                0.36

                Zhang 2005

                China

                Asian

                SSH

                Hospital (ASP)

                PCR-RFLP

                6

                33/76

                27

                6

                0

                68

                8

                0

                0.63

                Balding 2003

                Ireland

                Caucasian

                Sepsis

                Community

                PCR-RFLP

                6

                183/389

                113

                65

                5

                240

                125

                24

                0.16

                Treszl 2003

                Hungary

                Caucasian

                Sepsis

                Hospital (VLBW)

                PCR-RFLP

                6

                33/70

                20

                11

                2

                41

                25

                4

                0.94

                Fang 1999

                Germany

                Caucasian

                SS

                Community

                PCR

                7

                93/112

                55

                31

                7

                68

                33

                11

                0.03

                IL-1RN VNTR L/2

                              

                Zapata-Tarres 2013

                Mexico

                Hispanic

                SSH

                Hospital (ALL)

                PCR

                8

                22/35

                6

                11

                5

                23

                11

                1

                0.82

                Wan 2012

                China

                Asian

                Sepsis

                Hospital (transplanted)

                PCR-RFLP

                7

                21/60

                17

                4

                0

                51

                9

                0

                0.53

                Davis 2010

                America

                Hispanic

                Sepsis

                Community

                TaqMan

                7

                28/50

                12

                14

                2

                27

                20

                3

                0.78

                Garcia-Segarra 2007

                Spain

                Caucasian

                SS and SSH

                Community

                PCR

                7

                114/80

                59

                52

                3

                30

                41

                9

                0.37

                Watanabe 2005

                Japan

                Asian

                Sepsis

                Hospital (SIRS)

                PCR

                6

                68/45

                59

                 

                9a

                39

                 

                6a

                0.54

                Bessler 2004

                Israel

                Jews/Arabs

                Sepsis

                Community

                PCR

                7

                34/61

                18

                10

                6

                33

                16

                12

                0.002

                Balding 2003

                Ireland

                Caucasian

                Sepsis

                Community

                PCR-RFLP

                6

                183/389

                88

                70

                25

                198

                160

                31

                0.87

                Arnalich 2002

                Spain

                Caucasian

                SS

                Hospital (CAP)

                PCR

                8

                78/186

                32

                33

                13

                88

                81

                17

                0.79

                Ma 2002

                China

                Asian

                Sepsis

                Community

                PCR

                7

                60/60

                26

                27

                7

                36

                21

                3

                0.98

                Fang 1999

                Germany

                Caucasian

                SS

                Community

                PCR

                7

                93/261

                37

                43

                13

                152

                92

                17

                0.54

                SS: severe sepsis; SSH: septic shock; SIRS: systemic inflammatory response syndrome; ASP: acute severe pancreatitis; VLBW: very-low-birth-weight infants; ALL: acute lymphoblastic leukemia; CAP: community-acquired pneumonia; L signifies any long allele embracing allele 1, 3, 4, or 5; arepresents the number of AB + BB genotype (A represents the major allele, B represents the minor allele); PHWE < 0.05 is as a significant deviation from HWE.

                Quantitative data synthesis

                IL-1A-889 (rs1800587) polymorphism

                Only two studies [15, 17] with high quality containing 193 cases and 193 controls evaluated the association of the IL-1A-889 polymorphism (rs1800587) with sepsis risk. In overall comparison, a significant association was observed for allelic effect (OR = 1.47, 95% CI = 1.01-2.13, P = 0.04). There were no statistically significant associations between this polymorphism and sepsis risk under dominant or recessive models (Additional file 2: Figure S1, Table 2).
                Table 2

                Summary of meta-analysis results

                 

                Dominant model

                Recessive model

                Allelic model

                 

                n

                OR (95% CI)

                P-value

                Phet

                I2

                n

                OR (95% CI)

                P-value

                Phet

                I2

                n

                OR (95% CI)

                P-value

                Phet

                I2

                IL1A-889C/T

                               

                Total (sepsis)

                2

                1.49 (0.95-2.33)

                0.08

                0.65

                0%

                2

                2.06 (0.75-5.67)

                0.16

                0.56

                0%

                2

                1.47 (1.01-2.13)

                0.04

                0.98

                0%

                Ethnicity

                               

                Asian

                1

                1.41 (0.85-2.34)

                0.19

                  

                1

                2.65 (0.70-10.0)

                0.15

                  

                1

                1.47 (0.94-2.30)

                0.09

                  

                Others

                1

                1.81 (0.69-4.74)

                0.23

                  

                1

                1.44 (0.30-6.94)

                0.65

                  

                1

                1.46 (0.74-2.87)

                0.28

                  

                IL1B-511G/A

                               

                Total (sepsis)

                7

                0.81 (0.53-1.24)

                0.33

                <0.01

                68%

                6

                0.89 (0.53-1.50)

                0.66

                <0.01

                67%

                6

                0.82 (0.60-1.11)

                0.20

                <0.01

                69%

                Ethnicity

                               

                Asian

                4

                0.85 (0.39-1.87)

                0.69

                <0.01

                81%

                3

                0.67 (0.29-1.55)

                0.35

                0.02

                73%

                3

                0.74 (0.38-1.34)

                0.29

                <0.01

                84%

                Caucasian

                1

                0.86 (0.60-1.23)

                0.40

                  

                1

                0.68 (0.41-1.13)

                0.14

                  

                1

                0.84 (0.65-1.08)

                0.18

                  

                Others

                2

                0.63 (0.24-1.66)

                0.35

                0.09

                66%

                2

                1.73 (0.95-3.14)

                0.07

                0.76

                0%

                2

                0.98 (0.58-1.65)

                0.93

                0.18

                44%

                Quality score

                               

                ≥7

                6

                0.72 (0.48-1.9)

                0.12

                0.02

                64%

                6

                0.89 (0.53-1.50)

                0.66

                <0.01

                67%

                6

                0.82 (0.60-1.11)

                0.20

                <0.01

                69%

                <7

                1

                2.06 (0.94-4.55)

                0.07

                            

                IL1B-31C/T

                               

                Total (high quality)

                4

                1.29 (0.54-3.06)

                0.57

                <0.01

                86%

                4

                1.16 (0.86-1.56)

                0.34

                0.69

                0%

                4

                1.18 (0.78-1.77)

                0.43

                <0.01

                78%

                Ethnicity

                               

                Asian

                2

                2.19 (0.70-6.90)

                0.18

                <0.01

                89%

                2

                1.33 (0.84-2.09)

                0.22

                0.69

                0%

                2

                1.53 (0.91-2.57)

                0.11

                0.04

                77%

                Caucasian

                2

                0.73 (0.33-1.61)

                0.43

                0.15

                52%

                2

                1.04 (0.70-1.56)

                0.85

                0.40

                0%

                2

                0.90 (0.57-1.43)

                0.65

                0.14

                55%

                Sepsis severity

                               

                Sepsis

                3

                1.75 (0.74-4.11)

                0.20

                <0.01

                84%

                3

                1.24 (0.89-1.72)

                0.20

                0.85

                0%

                3

                1.37 (0.93-2.00)

                0.11

                0.03

                72%

                Severe sepsis

                1

                0.47 (0.20-1.10)

                0.08

                  

                1

                0.78 (0.36-1.71)

                0.54

                  

                1

                0.68 (0.40-1.15)

                0.15

                  

                Septic shock

                               

                IL1B + 3594C/T

                               

                Total

                6

                1.06 (0.86-1.31)

                0.57

                0.79

                0%

                5

                0.59 (0.36-0.97)

                0.04

                0.81

                0%

                6

                0.97 (0.81-1.15)

                0.72

                0.71

                0%

                Ethnicity

                               

                Asian

                1

                1.89 (0.60-5.96)

                0.28

                       

                1

                1.80 (0.60-5.41)

                0.30

                  

                Caucasian

                4

                1.00 (0.80-1.25)

                0.99

                0.74

                0%

                4

                0.57 (0.34-0.95)

                0.03

                0.74

                0%

                4

                0.92 (0.76-1.11)

                0.37

                0.99

                0%

                Others

                1

                1.48 (0.78-2.81)

                0.23

                  

                1

                0.94 (0.19-4.81)

                0.95

                  

                1

                1.34 (0.77-2.33)

                0.31

                  

                Sepsis severity

                               

                Sepsis

                4

                1.04 (0.83-1.30)

                0.75

                0.71

                0%

                4

                0.55 (0.31-0.97)

                0.04

                0.73

                0%

                4

                0.95 (0.78-1.15)

                0.59

                0.64

                0%

                Severe sepsis

                1

                1.07 (0.61-1.87)

                0.82

                  

                1

                0.75 (0.28-2.01)

                0.56

                  

                1

                0.98 (0.62-1.54)

                0.93

                  

                Septic shock

                1

                1.89 (0.60-5.96)

                0.28

                       

                1

                1.80 (0.60-5.41)

                0.30

                  

                Quality score

                               

                ≥7

                3

                1.08 (0.82-1.42)

                0.57

                0.55

                0%

                3

                0.63 (0.34-1.14)

                0.13

                0.71

                0%

                3

                0.98 (0.78-1.23)

                0.89

                0.47

                0%

                <7

                3

                1.04 (0.75-1.43)

                0.83

                0.56

                0%

                3

                0.53 (0.23-1.25)

                0.15

                0.37

                0%

                3

                0.95 (0.72-1.24)

                0.70

                0.49

                0%

                IL1RN VNTR L/2

                               

                Total

                9

                1.39 (0.97-1.98)

                0.07

                0.01

                59%

                8

                1.67 (0.93-3.02)

                0.09

                0.04

                54%

                8

                1.40 (1.01-1.95)

                0.04

                <0.01

                72%

                Ethnicity

                               

                Asian

                3

                1.55 (0.89-2.68)

                0.12

                0.58

                0%

                1

                2.51 (0.62-10.21)

                0.20

                  

                2

                1.69 (1.01-2.84)

                0.05

                0.64

                0%

                Caucasian

                4

                1.16 (0.72-1.88)

                0.54

                <0.01

                75%

                4

                1.39 (0.66-2.92)

                0.38

                0.02

                71%

                4

                1.17 (0.77-1.78)

                0.45

                <0.01

                82%

                Others

                2

                2.68 (0.84-8.50)

                0.09

                0.12

                58%

                2

                3.17 (0.40-25.32)

                0.28

                0.15

                52%

                2

                2.27 (0.78-6.58)

                0.13

                0.05

                73%

                Sepsis severity

                               

                Sepsis

                5

                1.26 (0.95-1.67)

                0.11

                0.69

                0%

                4

                1.85 (1.12-3.04)

                0.02

                0.82

                0%

                4

                1.31 (1.05-1.64)

                0.02

                0.70

                0%

                Severe sepsis

                2

                1.67 (1.03-2.71)

                0.04

                0.18

                44%

                2

                2.16 (1.25-3.72)

                0.01

                0.77

                0%

                2

                1.60 (1.18-2.17)

                <0.01

                0.25

                24%

                Septic shock

                1

                5.11 (1.59-16.46)

                0.01

                  

                1

                10.00 (1.08-92.49)

                0.04

                  

                1

                4.00 (1.72-9.31)

                <0.01

                  

                Quality score

                               

                ≥7

                7

                1.53 (0.95-2.47)

                0.08

                <0.01

                67%

                7

                1.62 (0.72-3.65)

                0.24

                0.02

                61%

                7

                1.46 (0.96-2.21)

                0.08

                <0.01

                75%

                <7

                2

                1.11 (0.79-1.55)

                0.55

                0.84

                0%

                1

                1.83 (1.04-3.20)

                0.03

                  

                1

                1.22 (0.93-1.60)

                0.14

                  

                Random effects model is used whether or not heterogeneity exists; others contain African-American, Hispanic, and Jews/Arabs; n: the number of studies involved. OR: odds ratio; CI: confidence interval; P-value: P value of pooled OR; Phet: P of heterogeneity; Statistically significant results (P < 0.05) are highlighted in bold.

                IL-1B-511 (rs16944) and −31 (rs1143627) polymorphisms

                Seven studies [1215, 17, 34] totaling 745 cases and 750 controls were identified in order to investigate the association between IL-1B-511 polymorphism (rs16944) and sepsis risk. Overall, the results showed no associations under any genetic model. Removal of the low score study ([34] with score = 6), did not alter these results. In addition, there was no association in any subgroup analysis, either based on ethnicity or sepsis severity under any genetic model (Additional file 2: Figure S2, Table 2).

                For the IL-1B-31 polymorphism (rs1143627), four studies [1416, 22] with high quality totaling 405 cases and 824 controls were identified. Similar to IL-1B-511 polymorphism, there were no significant associations detected between rs1143627 and sepsis risk overall or in any subgroup analysis for any genetic model (Additional file 2: Figure S3, Table 2).

                IL-1B + 3594 (rs143634) polymorphism

                Six studies [13, 20, 23, 24, 27] containing 680 cases and 998 controls were identified that evaluated the association between the IL-1B + 3594 polymorphism (rs143634) and sepsis risk. In the overall comparison, the IL-1B + 3594 polymorphism was significantly associated with sepsis risk in the recessive effect (OR = 0.59, 95% CI = 0.36-0.97, P = 0.04, PFDR = 0.12) (Figure 2, Additional file 2: Figure S4). In the subgroup analyses based on ethnicity and sepsis subtype, the significant results persisted in the Caucasian populations (OR = 0.57, 95% CI = 0.34-0.95, P = 0.03, PFDR = 0.09) and in sepsis subgroup patients (OR = 0.55, 95% CI = 0.31-0.97, P = 0.04, PFDR = 0.12). However, the negative results for Asians, severe sepsis, and septic shock group patients might be not reliable because only one study was performed in each subgroup (Table 2). After the exclusion of the study by Fang et al. [27], whose genotypic distribution in controls deviated from HWE (PHWE = 0.03), the results did not vary significantly (OR = 0.55, 95% CI = 0.31-0.97, P = 0.04, PFDR = 0.12 for overall studies; OR = 0.51, 95% CI = 0.28-0.93, P = 0.03, PFDR = 0.09 for Caucasian populations). Furthermore, the results of stratified analysis based on quality score were not statistically significant.
                http://static-content.springer.com/image/art%3A10.1186%2F1471-2350-15-8/MediaObjects/12881_2013_1167_Fig2_HTML.jpg
                Figure 2

                Forest plot of sepsis susceptibility associated with IL-1B + 3594 polymorphism under the recessive model (TT vs. CT + CC). The squares and horizontal line represent the individual study-specific OR and 95% CI. Area of squares is proportional to the weight of the individual study to the overall pooled OR. The diamond at the bottom of the graph represents the pooled OR and 95% CI. Events1: Number of individuals with TT genotype. OR, odds ratio; CI, confidence interval.

                IL-1RN VNTR polymorphism

                For the IL-1RN VNTR polymorphism, ten studies [11, 12, 17, 19, 21, 2427, 34] comprised of 701 cases and 1227 controls were identified. However, one study by Bessler et al. [21] that deviated from HWE (PHWE = 0.002) was not included into the final meta-analysis. The overall results suggested there was statistically significant association of this polymorphism with sepsis risk under allelic model (OR = 1.40, 95% CI = 1.01-1.95, P = 0.04, PFDR = 0.12) (Figure 3, Additional 1: Additional file 2: Figure S5). A similar trend was observed in Asian patients (OR = 1.69, 95% CI = 1.01-2.84) although the results were not statistically significant (P = 0.05, PFDR = 0.15). Further stratified analyses based on sepsis severity showed that the effect sizes of IL-1RN VNTR on sepsis risk increased with disease severity (septic shock patients > severe sepsis patients > sepsis patients). These findings needed to be interpreted with caution since only one or two studies were included under the three genetic models. Furthermore, stratified analysis based on quality score indicated that there was not significant association in the high quality studies (Quality score ≥7) (Table 2).
                http://static-content.springer.com/image/art%3A10.1186%2F1471-2350-15-8/MediaObjects/12881_2013_1167_Fig3_HTML.jpg
                Figure 3

                Forest plot of sepsis susceptibility associated with IL-1RN VNTR polymorphism under the allelic model (2 vs. L). The squares and horizontal line represent the individual study-specific OR and 95% CI. Area of squares is proportional to the weight of the individual study to the overall pooled OR. The diamond at the bottom of the graph represents the pooled OR and 95% CI. Events1: Number of the 2 allele. OR, odds ratio; CI, confidence interval.

                Heterogeneity analysis

                As shown in Table 2, obvious evidence (P < 0.1 and I2 > 50%) for heterogeneity between studies was found for IL-1B-511 or IL-1RN VNTR under all three genetic models, and for IL-1B-31 under dominant and allelic models. No evidence for heterogeneity between studies was found for IL-1A-889 or IL-1B + 3594 under any genetic model.

                To explore potential sources of between-study heterogeneity in our assessment of IL-1RN VNTR polymorphism and sepsis susceptibility, meta-regression was conducted for all three genetic models. The confounding factors included ethnicity, sepsis severity, sources of controls, and sample size. However, the result did not indicate that any of these potential factors was a major source of heterogeneity (P-value for regression all > 0.05) (Additional file 3: Table S2-S4). Indeed, the heterogeneity might be attributable to other factors, which regrettably remain undefined due to insufficient data. For the other two polymorphisms (IL-1B-511 and −31), meta-regression was not performed due to the small number of included studies.

                Sensitivity analysis

                We removed one study per time from the overall pooled analysis to evaluate the influence of the removed data set on the pooled ORs. The corresponding pooled ORs under any genetic model were not materially altered for IL-1A-889, IL-1B-511, and −31, respectively (Additional file 4: Table S5-S7). However, for IL-1B + 3594, two studies (Johnson-1 et al. [13] and Balding et al. [24]) altered the corresponding statistical P value of association under the recessive model (Additional file 4: Table S8b). For IL-1RN VNTR, one study (Garcia-Segarra et al. [19]) was identified as the main cause of heterogeneity. After exclusion of this study, the heterogeneity no longer existed, moreover, positive association was increased under all three genetic models (Additional file 4: Table S9).

                Publication bias

                Publication bias was examined by funnel plots and Egger’s test under all genetic models. After combining all studies, a little asymmetry was observed for IL-1RN VNTR polymorphism (Figures 4, 5 and 6), but Egger’s test did not show evidence of publication bias (dominant: P = 0.519, recessive: P = 0.724, allelic: P = 0.640). For IL-1A-889, IL-1B-511, -31, and +3594 polymorphisms, publication bias testing was not performed due to the small number of included studies (n < 9).
                http://static-content.springer.com/image/art%3A10.1186%2F1471-2350-15-8/MediaObjects/12881_2013_1167_Fig4_HTML.jpg
                Figure 4

                Funnel plot of sepsis susceptibility associated with IL-1RN VNTR under the dominant model (2/2 + L/2 vs. L/L). Each circle represents an independent study; for each study the OR was plotted against the standard error of the log of the OR. Center dotted line represents the pooled OR and sloping dotted lines represent the 95% CI of the pooled OR. OR, odds ratio; SE, standard error; CI, confidence interval.

                http://static-content.springer.com/image/art%3A10.1186%2F1471-2350-15-8/MediaObjects/12881_2013_1167_Fig5_HTML.jpg
                Figure 5

                Funnel plot of sepsis susceptibility associated with IL-1RN VNTR under the recessive model (2/2 vs. L/2 + L/L). Each circle represents an independent study; for each study the OR was plotted against the standard error of the log of the OR. Center dotted line represents the pooled OR and sloping dotted lines represent the 95% CI of the pooled OR. OR, odds ratio; SE, standard error; CI, confidence interval.

                http://static-content.springer.com/image/art%3A10.1186%2F1471-2350-15-8/MediaObjects/12881_2013_1167_Fig6_HTML.jpg
                Figure 6

                Funnel plot of sepsis susceptibility associated with IL-1RN VNTR under the allelic model (2 vs. L). Each circle represents an independent study; for each study the OR was plotted against the standard error of the log of the OR. Center dotted line represents the pooled OR and sloping dotted lines represent the 95% CI of the pooled OR. OR, odds ratio; SE, standard error; CI, confidence interval.

                Discussion

                In this meta-analysis, two polymorphisms (IL-1B + 3594 and IL-1RN VNTR) were significantly associated with sepsis susceptibility in overall comparison and subgroup analyses based on sepsis severity, whereas IL-1A-889 polymorphism influenced sepsis risk only in overall comparison. In contrast, no association was observed between either IL-1B-511 or −31 and sepsis risk in overall comparison or subgroup analyses.

                IL-1B + 3594 polymorphism is a coding synonymous variant located in exon 5 of IL-1B. The transition from C to T does not change amino acid coding but may lead to an inactivation of the original splicing donor site. The alternative splicing results in a premature stop codon or exon skipping and produces a truncated protein that is likely to be rapidly degraded or functionally inactive [35]. The IL1B + 3954 T allele has been reported to increase the production of IL-1β protein in response to LPS-stimulation [36]. The results of our meta-analysis revealed that individuals with variant genotype (TT) were less susceptible to sepsis than individuals with CC or CT genotypes in overall comparison and Caucasian population, which was inconsistent with higher IL-1β levels associated with increased risk of sepsis. Considering that sepsis is a multifactorial trait and the impact of the inflammatory cytokine on sepsis progress may be modulated by other environmental and genetic factors, more studies should be conducted to clarify the role of IL-1B + 3594 polymorphism in the etiology of sepsis.

                For the IL-1RN VNTR polymorphism, functional analysis in vitro has shown that the IL-1RN-2 allele correlated with high IL-1ra level and an even more elevated IL-1β level. This resulted in the lowest IL-1ra/IL-1β ratio and was associated with a strengthened and prolonged inflammatory response [37, 38]. In addition, Arnalich et al. [26] found that IL-1RN-2 allele causes a decreased production of serum IL-1Ra in patients with severe sepsis and ethnically matched healthy controls compared with 1 allele. These findings implied that the 86 bp VNTR polymorphism of the IL-1RN has potential roles in regulating the immune response and contributed to the pathogenesis of inflammatory diseases. Similarly, our meta-analysis indicated a significant association with risk of sepsis in overall comparison and stratified analysis based on different sepsis severity, which was not observed in ethnicity subgroup analysis. This indicates that the discrepancies between the overall and ethnicity subgroup analyses may be attributed to the diverse genetic backgrounds and environmental factors influencing sepsis risk in different ethnic populations. Further studies with larger samples and from homogeneous populations are warranted to further evaluate the role of the IL-1RN VNTR polymorphism in sepsis risk in different populations.

                IL-1A-889 polymorphism, a C-to-T point mutation in its 5’ regulatory region, affected over-expression of IL-1α [35]. In the current meta-analysis, there was significant association with sepsis susceptibility in overall comparison. However, only two studies were included into this meta-analysis with small samples. Thus, this finding needed to be confirmed with larger samples.

                The −511 and −31 polymorphisms, which are located at position 511 bp and 31 bp upstream of the transcriptional start site, have been shown to influence the transcriptional activity and expression of the IL-1B gene. The presence of variant allele of IL-1B-511 markedly increased endotoxin-induced production of IL-1β [36]. Moreover, IL1B-31C/T substitution located in the TATA box motif has been found to markedly affect the binding of several transcription factors and thereby affect the transcriptional activity [39]. In addition, two bi-allelic SNPs (−511, and −31) within the human IL-1B promoter region have been reported to affect LPS-induced IL-1β transcription in vitro and IL-1β plasma levels in healthy adults [40]. Although IL-1β plays an important role in sepsis and IL-1β is frequently over-expressed in sepsis, our meta-analysis indicated no significant association between the IL-1B-511 and −31 polymorphisms and sepsis risk, suggesting that IL-1β expression might influence sepsis progression via mechanisms other than regulation by the two promoter polymorphisms. Several other factors, such as IL-1RN and NLRP3 may also regulate IL-1β expression [41, 42]. Further studies are needed to test these hypotheses.

                Sepsis is a multifactorial trait and the impact of the inflammatory cytokine on sepsis progress may be modulated by, age, gender and some other environmental factors [43]. Interpretation of the pooled results has been hampered by the fact that several different clinical conditions such as sepsis, severe sepsis, or septic shock have been analyzed together according to the published consensus definitions for sepsis [44]. In our stratified analyses, we also examined that whether the effect of polymorphisms differed depending on the way in which sepsis was described (sepsis, severe sepsis, or septic shock). Our results indicated the positive association was observed for IL-1B + 3594C/T in sepsis group patients, for IL-1RN VNTR polymorphism in sepsis, severe sepsis, and septic shock group patients, respectively. These findings indicated that the way in which sepsis was described affected the association between IL-1 polymorphisms and susceptibility to sepsis. However, what also needs to be pointed out is that these significant associations were derived from only one to two studies and thus the result should be interpreted with caution because of the relatively small sample size.

                Heterogeneity is an important problem when interpreting the results of our meta-analysis. In this study, significant heterogeneity was found for the IL-1B-511, -31, and IL-1RN VNTR polymorphisms. Meta-regression did not seem to reveal the potential sources of heterogeneity with the introduction of covariates containing ethnicity, sepsis severity, sources of controls, sample size, which indicated that the heterogeneity might be attributable to other factors, which regrettably remain undefined due to insufficient data. Moreover, we carried out sensitivity analysis. Removal of each study did not seem to alter the relationships with sepsis risk and heterogeneity for IL-1B-511 and −31, suggesting the reliability of these results. However, removing one study by Garcia-Segarra et al. for IL-1RN VNTR obviously decreased the heterogeneity and increased positive association under all genetic models, which indicated this study may be the main cause of heterogeneity.

                Another important problem is publication bias. Because meta-analyses review quantitative data from numerous studies, the publication bias effect of the literature incorporated in the study can bias the mea-analytic outcome. For IL-1RN VNTR polymorphism, although the Egger’s test did not show significant publication bias for sepsis risk, we found the shape of the funnel plot was slightly asymmetrical. Thus, the results should be interpreted cautiously and more studies are still needed to confirm the findings from this meta-analysis.

                Some limitations of this meta-analysis should be pointed out. First, the number and sample size of the included studies was limited, some unpublished reports, non-English articles and studies without sufficient information were not included in our meta-analysis, which might bias the pooled results. Second, although the results in stratified analysis were more meaningful, there were a small number of studies in each stratum, thus limiting the interpretation of these analyses. Third, as none of the studies included in this meta-analysis considered the effect of gene-gene/environment involved in the pathogenesis of sepsis, this issue could not be addressed. Fourth, the overall outcome was based on unadjusted data, where as a more precise analysis stratified by variables such as age, sex, type of infection etc. could not be performed due to limitations of the data which also restricted our ability to detect possible sources of heterogeneity. Fifth, stratified analyses based on the different sources of controls were not performed due to small number of studies in each subgroup; the inclusion of studies with varied control populations might increase the probability of typeIerror and bias the pooled results. Finally, as we only focused on the associations between IL-1 polymorphisms and sepsis susceptibility in the present study, the significance was limited. To better illuminate the role of IL-1 polymorphisms in outcome of sepsis, it would also be important to perform meta-analyses on the associations between polymorphisms and severity or sepsis-related mortality in future studies.

                Conclusions

                To our knowledge, this is the first study that quantitatively synthesized the association between the IL-1 polymorphisms and sepsis. The results demonstrated that the IL-1A-889C/T, IL-1B-3594C/T, and IL-1RN VNTR polymorphisms had significant associations with the risk of sepsis, although some results were limited by the small number of studies. However, no significant association existed between IL-1B-511, -31 and sepsis risk. Further studies with large samples and homogeneous population are needed to evaluate their associations with sepsis risk.

                Abbreviations

                IL-1: 

                Interleukin-1

                IL-1RN: 

                Interleukin-1 receptor antagonist

                VNTR: 

                Variable number of tandem repeats

                OR: 

                Odds ratio

                CI: 

                Confidence interval

                HWE: 

                Hardy-Weinberg equilibrium

                NOS: 

                Newcastle-Ottawa quality assessment scale

                PCR-RFLP: 

                Polymerase chain reaction-restriction fragment length polymorphism.

                Declarations

                Acknowledgements

                This work is supported by National Key Technology R&D Program (2012BAI11B01), Hundreds of outstanding science and technology leading talent research fund in Chongqing City, The Major State Basic Research Development Program of China (2012CB518102), National Natural Science Funds for Distinguished Young Scholar (81201462), and Open fund of State Key Laboratory of Trauma, Burns and Combined Injury, Third Military Medical University (SKLZZ201104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

                Authors’ Affiliations

                (1)
                State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Surgery Research, Daping Hospital, Third Military Medical University

                References

                1. Rittirsch D, Flierl MA, Ward PA: Harmful molecular mechanisms in sepsis. Nat Rev Immunol 2008,8(10):776–787.PubMed CentralPubMedView Article
                2. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003,348(16):1546–1554.PubMedView Article
                3. Grealy R, White M, Stordeur P, Kelleher D, Doherty DG, McManus R, Ryan T: Characterising cytokine gene expression signatures in patients with severe sepsis. Mediators Inflamm 2013, 2013:164246.PubMed CentralPubMedView Article
                4. Wen AQ, Gu W, Zeng L, Zhou J, Jiang DP, Zhang L, Du DY, Hu P, Chen K, Liu Q, Wang ZG, Jiang JX: Clinical relevance of IL-1beta promoter polymorphisms (-1470, -511, and -31) in patients with Chinese major trauma patients. Shock 2010,33(6):576–582.PubMedView Article
                5. Kurt AN, Aygun AD, Godekmerdan A, Kurt A, Dogan Y, Yilmaz E: Serum IL-1beta, IL-6, IL-8, and TNF-alpha levels in early diagnosis and management of neonatal sepsis. Mediators Inflamm 2007, 2007:31397.PubMed CentralPubMedView Article
                6. Fida NM, Al-Mughales J, Farouq M: Interleukin-1alpha, interleukin-6 and tumor necrosis factor-alpha levels in children with sepsis and meningitis. Pediatr Int 2006,48(2):118–124.PubMedView Article
                7. Pruitt JH, Copeland EM 3rd, Moldawer LL: Interleukin-1 and interleukin-1 antagonism in sepsis, systemic inflammatory response syndrome, and septic shock. Shock 1995,3(4):235–251.PubMedView Article
                8. Opal SM, Fisher CJ Jr, Dhainaut JF, Vincent JL, Brase R, Lowry SF, Sadoff JC, Slotman GJ, Levy H, Balk RA, Shelly MP, Pribble JP, LaBrecque JF, Lookabaugh J, Donovan H, Dubin H, Baughman R, Norman J, DeMaria E, Matzel K, Abraham E, Seneff M: Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The interleukin-1 receptor antagonist sepsis investigator group. Crit Care Med 1997,25(7):1115–1124.PubMedView Article
                9. Dinarello CA: Biologic basis for interleukin-1 in disease. Blood 1996,87(6):2095–2147.PubMed
                10. Vamvakopoulos JE, Taylor CJ, Morris-Stiff GJ, Green C, Metcalfe S: The interleukin-1 receptor antagonist gene: a single-copy variant of the intron 2 variable number tandem repeat (VNTR) polymorphism. Eur J Immunogenet 2002,29(4):337–340.PubMedView Article
                11. Zapata-Tarres M, Arredondo-Garcia JL, Rivera-Luna R, Klunder-Klunder M, Mancilla-Ramirez J, Sanchez-Urbina R, Vazquez-Cruz MY, Juarez-Villegas LE, Palomo-Colli MA: Interleukin-1 receptor antagonist gene polymorphism increases susceptibility to septic shock in children with acute lymphoblastic leukemia. Pediatr Infect Dis J 2013,32(2):136–139.PubMedView Article
                12. Wan QQ, Ye QF, Ma Y, Zhou JD: Genetic association of interleukin-1(beta) (−511C/T) and its receptor antagonist (86-bpVNTR) gene polymorphism with susceptibility to bacteremia in kidney transplant recipients. Transplant Proc 2012,44(10):3026–3028.PubMedView Article
                13. Johnson MD, Plantinga TS, Van De Vosse E, Velez Edwards DR, Smith PB, Alexander BD, Yang JC, Kremer D, Laird GM, Oosting M, Joosten LAB, Van Der Meer JWM, Van Dissel JT, Walsh TJ, Perfect JR, Kullberg BJ, Scott WK, Netea MG: Cytokine gene polymorphisms and the outcome of invasive candidiasis: A prospective cohort study. Clin Infect Dis 2012,54(4):502–510.PubMedView Article
                14. Shimada T, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Watanabe E, Abe R, Nakada T-a, Tateishi Y, Otani S, Hirasawa H, Tokuhisa T, Uno H: Outcome prediction in sepsis combined use of genetic polymorphisms - A study in Japanese population. Cytokine 2011,54(1):79–84.PubMedView Article
                15. Gu W, Zeng L, Zhou J, Jiang DP, Zhang L, Du DY, Hu P, Chen K, Liu Q, Wang ZG, Jiang JX: Clinical relevance of 13 cytokine gene polymorphisms in Chinese major trauma patients. Intensive Care Med 2010,36(7):1261–1265.PubMedView Article
                16. Emonts M, Vermont CL, Houwing-Duistermaat JJ, Haralambous E, Gaast-de Jongh CE, Hazelzet JA, Faust SN, Betts H, Hermans PWM, Levin M, de Groot R, St Mary's Imperial Coll G, Erasmus MCSCsH: Polymorphisms in parp, Il1b, Il4, Il10, C1inh, Defb1, and Defa4 in meningococcal disease in three populations. Shock 2010,34(1):17–22.PubMedView Article
                17. Davis SM, Clark EA, Nelson LT, Silver RM: The association of innate immune response gene polymorphisms and puerperal group a streptococcal sepsis. Am J Obstet Gynecol 2010,202(3):e301–308.View Article
                18. Motoyama S, Miura M, Hinai Y, Maruyama K, Usami S, Nakatsu T, Saito H, Minamiya Y, Murata K, Suzuki T, Ogawa J: Interferon-gamma 874A > T genetic polymorphism is associated with infectious complications following surgery in patients with thoracic esophageal cancer. Surgery 2009,146(5):931–938.PubMedView Article
                19. Garcia-Segarra G, Espinosa G, Tassies D, Oriola J, Aibar J, Bove A, Castro P, Reverter J-C, Nicolas J-M: Increased mortality in septic shock with the 4G/4G genotype of plasminogen activator inhibitor 1 in patients of white descent. Intensive Care Med 2007,33(8):1354–1362.PubMedView Article
                20. Zhang DL, Zheng HM, Yu BJ, Jiang ZW, Li JS: Association of polymorphisms of IL and CD14 genes with acute severe pancreatitis and septic shock. World J Gastroenterol 2005,11(28):4409–4413.PubMed
                21. Bessler H, Osovsky M, Sirota L: Association between IL-1ra gene polymorphism and premature delivery. Biol Neonate 2004,85(3):179–183.PubMedView Article
                22. Barber RC, Aragaki CC, Rivera-Chavez FA, Purdue GF, Hunt JL, Horton JW: TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severe sepsis following burn injury. J Med Genet 2004,41(11):808–813.PubMedView Article
                23. Treszl A, Kocsis I, Szathmari M, Schuler A, Heninger E, Tulassay T, Vasarhelyi B: Genetic variants of TNF-[FC12]a, IL-1beta, IL-4 receptor [FC12]a-chain, IL-6 and IL-10 genes are not risk factors for sepsis in low-birth-weight infants. Biol Neonate 2003,83(4):241–245.PubMedView Article
                24. Balding J, Healy CM, Livingstone WJ, White B, Mynett-Johnson L, Cafferkey M, Smith OP: Genomic polymorphic profiles in an Irish population with meningococcaemia: is it possible to predict severity and outcome of disease? Genes Immun 2003,4(8):533–540.PubMedView Article
                25. Ma P, Chen D, Pan J, Du B: Genomic polymorphism within interleukin-1 family cytokines influences the outcome of septic patients. Crit Care Med 2002,30(5):1046–1050.PubMedView Article
                26. Arnalich F, Lopez-Maderuelo D, Codoceo R, Lopez J, Solis-Garrido LM, Capiscol C, Fernandez-Capitan C, Madero R, Montiel C: Interleukin-1 receptor antagonist gene polymorphism and mortality in patients with severe sepsis. Clin Exp Immunol 2002,127(2):331–336.PubMed CentralPubMedView Article
                27. Fang XM, Schroder S, Hoeft A, Stuber F: Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis. Crit Care Med 1999,27(7):1330–1334.PubMedView Article
                28. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Health Research Institute; 2011. http://​www.​ohri.​ca/​programs/​clinical_​epidemiology/​oxford.​asp. Accessed 20 October 2011
                29. Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ 2003,327(7414):557–560.PubMedView Article
                30. Schmid CH, Stark PC, Berlin JA, Landais P, Lau J: Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors. J Clin Epidemiol 2004,57(7):683–697.PubMedView Article
                31. Sutton AJ, Duval SJ, Tweedie RL, Abrams KR, Jones DR: Empirical assessment of effect of publication bias on meta-analyses. BMJ 2000,320(7249):1574–1577.PubMedView Article
                32. Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 1997,315(7109):629–634.PubMedView Article
                33. Noble WS: How does multiple testing correction work? Nat Biotechnol 2009,27(12):1135–1137.PubMed CentralPubMedView Article
                34. Watanabe E, Hirasawa H, Oda S, Shiga H, Matsuda K, Nakamura M, Abe R, Nakada T: Cytokine-related genotypic differences in peak interleukin-6 blood levels of patients with SIRS and septic complications. J Trauma 2005,59(5):1181–1189. discussion 1189–1190PubMedView Article
                35. Shirodaria S, Smith J, McKay IJ, Kennett CN, Hughes FJ: Polymorphisms in the IL-1A gene are correlated with levels of interleukin-1alpha protein in gingival crevicular fluid of teeth with severe periodontal disease. J Dent Res 2000,79(11):1864–1869.PubMedView Article
                36. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J: A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992,22(6):396–402.PubMedView Article
                37. Witkin SS, Gerber S, Ledger WJ: Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis 2002,34(2):204–209.PubMedView Article
                38. Lim WY, Chen Y, Ali SM, Chuah KL, Eng P, Leong SS, Lim E, Lim TK, Ng AW, Poh WT, Tee A, Teh M, Salim A, Seow A: Polymorphisms in inflammatory pathway genes, host factors and lung cancer risk in Chinese female never-smokers. Carcinogenesis 2011,32(4):522–529.PubMedView Article
                39. Chen H, Wilkins LM, Aziz N, Cannings C, Wyllie DH, Bingle C, Rogus J, Beck JD, Offenbacher S, Cork MJ, Rafie-Kolpin M, Hsieh CM, Kornman KS, Duff GW: Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 2006,15(4):519–529.PubMedView Article
                40. Wen AQ, Wang J, Feng K, Zhu PF, Wang ZG, Jiang JX: Effects of haplotypes in the interleukin 1beta promoter on lipopolysaccharide-induced interleukin 1beta expression. Shock 2006,26(1):25–30.PubMedView Article
                41. Santtila S, Savinainen K, Hurme M: Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 1998,47(3):195–198.PubMedView Article
                42. Weber A, Wasiliew P, Kracht M: Interleukin-1beta (IL-1beta) processing pathway. Sci Signal 2010,3(105):cm2.PubMed
                43. Watanabe E, Buchman TG, Hirasawa H, Zehnbauer BA: Association between lymphotoxin-(alpha) (tumor necrosis factor-(beta)) intron polymorphism and predisposition to severe sepsis is modified by gender and age. Crit Care Med 2010,38(1):181–193.PubMedView Article
                44. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003,31(4):1250–1256.PubMedView Article
                45. Pre-publication history

                  1. The pre-publication history for this paper can be accessed here: http://​www.​biomedcentral.​com/​1471-2350/​15/​8/​prepub

                Copyright

                © Zhang et al.; licensee BioMed Central Ltd. 2014

                This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.